炎症性肠病中的小肠癌风险:来自美国大型多中心数据库的倾向匹配研究
该研究利用TriNetX数据库2005至2024年电子健康记录,经倾向评分匹配比较炎症性肠病、溃疡性结肠炎和克罗恩病患者与一般人群的小肠癌发生率。2010至2024年炎症性肠病患者诊断的小肠癌呈上升趋势,年均百分比变化为3.2%(P<0.001)。克罗恩病(aHR=4.83;95%CI:3.58-6.53;P<.0001)和溃疡性结肠炎(aHR=2.28;95%CI:1.65-3.14;P<.0001)患者小肠癌风险均高于无炎症性肠病的一般人群,回肠为所有亚组中最常见部位。
要点
- 2010至2024年炎症性肠病患者诊断的小肠癌呈上升趋势,AAPC为3.2%(P<0.001)。
- 克罗恩病患者小肠癌风险高于一般人群(aHR=4.83;95%CI:3.58-6.53;P<.0001)。
- 溃疡性结肠炎患者小肠癌风险亦高于一般人群(aHR=2.28;95%CI:1.65-3.14;P<.0001),回肠为最常见部位。
核心结论
- 克罗恩病和溃疡性结肠炎患者发生小肠癌的风险均高于一般人群。
研究设计与样本
- 使用TriNetX数据库获取2005至2024年炎症性肠病、溃疡性结肠炎和克罗恩病患者的电子健康记录。
- 采用倾向评分匹配比较炎症性肠病、溃疡性结肠炎和克罗恩病患者与一般人群的小肠癌发生率,并调整所有已知混杂因素。
主要发现
- 2010至2024年炎症性肠病患者诊断的小肠癌呈上升趋势,年均百分比变化(AAPC)为3.2%(P<0.001)。
- 克罗恩病患者较无炎症性肠病的一般人群小肠癌风险升高(aHR=4.83;95%CI:3.58-6.53;P<.0001)。
- 溃疡性结肠炎患者较无炎症性肠病的一般人群小肠癌风险升高(aHR=2.28;95%CI:1.65-3.14;P<.0001)。
- 回肠为所有亚组中最常见的小肠癌部位。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The risk of small bowel cancer (SBC) in inflammatory bowel disease (IBD) is unclear. We compared the recent trends of SBC in patients with IBD and stratified them based on disease type. METHODS: We used TriNetX database to access the electronic health records for patients with IBD, ulcerative colitis (UC), and Crohn's disease (CD) from 2005 to 2024. We used propensity score matching to compare the rate of SBC in patients with IBD, UC, and CD compared with the general population. We adjusted for all known confounders. RESULTS: From 2010-2024, there was an increasing trend of diagnosed SBC in patients with IBD, with an Average Annual Percentage Change (AAPC) of 3.2% (P<0.001). Patients with CD (aHR = 4.83; 95% CI: 3.58 - 6.53; P < .0001) had an increased risk of SBC compared to the general population without IBD, as well as patients with UC (aHR = 2.28; 95% CI: 1.65 - 3.14; P < .0001). The ileum was the most common location across all subgroups. CONCLUSION: Both patients with CD and, interestingly, UC had an elevated risk of developing SBC compared with the general population.
引用
- Alsakarneh S, Ahmed M, Azim S, et al. Risk of Small Intestine Cancer in Inflammatory Bowel Disease: A Propensity-Matched Study From a Large Multicenter Database in the United States. Am J Gastroenterol. 2024. PMID: 39051646. doi:10.14309/ajg.0000000000002984
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。